{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "complex_factors": [
        "3x Leverage",
        "Inverse Exposure",
        "Fully Collateralised Swap Structure",
        "Use of Total Return Swaps",
        "Counterparty Risk",
        "Daily Reset and Compounding Effects",
        "Short Exposure to Equity Index"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree EURO STOXX Banks 3x Daily Short is a fully collateralised, UCITS eligible Exchange Traded Product (ETP) that provides leveraged short exposure (-3x) to the EURO STOXX Banks EUR Gross Return Index. The product uses a fully collateralised swap structure to achieve its investment objective, explicitly referencing swap agreements and collateral held at The Bank of New York Mellon. The replication method is synthetic, relying on total return swaps rather than physical replication of underlying securities. The product is leveraged with a factor of -3x and provides inverse exposure, which are key complexity triggers under MiFID II. The product carries significant counterparty risk due to reliance on swap counterparties, with collateral management and credit risk disclosures. The risk indicator is at the highest level (7/7), indicating very high risk. The product is not UCITS compliant despite being UCITS eligible, and it is structured as a debt security rather than a traditional ETF. The daily reset of leverage and compounding effects add further complexity, making returns over periods longer than one day non-linear and difficult to predict. The product is intended only for informed or sophisticated investors with specific knowledge of leveraged and inverse ETPs. Costs include swap fees embedded in the management fee and transaction costs. The product\u2019s complexity is driven primarily by its synthetic swap-based replication, leverage, inverse exposure, and counterparty risk, all of which align with MiFID II criteria for complex financial instruments."
}